KCM
MDCO

Kennedy Capital Management’s Medicines Co MDCO Stock Holding History

Kennedy Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-149,590
Closed -$4.28M – 765
2015
Q2 		$4.28M Buy
+149,590
New +$4.17M 0.08% 430

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kennedy Capital Management's MDCO Position: Q3 2015 in Review

Kennedy Capital Management sold out of Medicines Co (MDCO) in Q3 2015, closing a stake of 149,590 shares — an estimated $4.28M sold.

Kennedy Capital Management first reported a position in MDCO in Q2 2015 and held it in 1 quarter. The position peaked at $4.28M in Q2 2015. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

  • Kennedy Capital Management reported no remaining Medicines Co position as of Q3 2015 after selling out during the quarter.
  • Kennedy Capital Management sold 149,590 Medicines Co shares in Q3 2015, an estimated $4.28M.
  • Kennedy Capital Management first reported a position in Medicines Co in Q2 2015 and held it in 1 quarter.
  • Kennedy Capital Management's Medicines Co position peaked at $4.28M in Q2 2015.
  • 183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on Kennedy Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.